Skip content
Equine

Equine

Equine

vet-health-management

EquiCoxib™ (firocoxib)

Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Product Image
Get Aurora

vet-health-management

EquiCoxib™ (firocoxib)

Package Presentation

90mL

Reorder No: 28008

400mL

Reorder No: 28009

Get Aurora

Product
Features

  • Proven pharmacokinetic, bioequivalence to Equioxx® Paste in a blinded, controlled cross-over study
  • Accurate dosing based on the actual weight of the horse
  • Newly designed draw-off-cap and syringe for easier, economical dispensing
  • Flavorless oral solution horses readily consume
  • Approved by FDA under ANADA 200-766
  • Manufactured under GMP standards for quality and consistency

Safety
Info

For oral use in horses only. Do not inject EquiCoxib™. Do not use in horses intended for human consumption. EquiCoxib™ is contraindicated in horses with a hypersensitivity to firocoxib. As with any prescription medication, prior to use, a veterinarian should perform a physical examination and review the horse’s medical history. Treatment with EquiCoxib™ should be terminated if signs such as inappetance, colic, abnormal feces, or lethargy are observed. As a class, nonsteroidal anti-inflammatory drugs may be associated with gastrointestinal, hepatic and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. EquiCoxib™ has not been evaluated in horses less than 1 year of age or in breeding horses, or pregnant or lactating mares. Keep out of the reach of children. For complete safety information, refer to the package insert.

Safety
Info

For oral use in horses only. Do not inject EquiCoxib™. Do not use in horses intended for human consumption. EquiCoxib™ is contraindicated in horses with a hypersensitivity to firocoxib. As with any prescription medication, prior to use, a veterinarian should perform a physical examination and review the horse’s medical history. Treatment with EquiCoxib™ should be terminated if signs such as inappetance, colic, abnormal feces, or lethargy are observed. As a class, nonsteroidal anti-inflammatory drugs may be associated with gastrointestinal, hepatic and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. EquiCoxib™ has not been evaluated in horses less than 1 year of age or in breeding horses, or pregnant or lactating mares. Keep out of the reach of children. For complete safety information, refer to the package insert.

Cookies & Privacy

Our website uses cookies. By using our website and agreeing to this policy, you consent to our use of cookies in accordance with our Privacy Policy and our Terms and Conditions.